Skip to content

A real-world study of different reconstruction modalities for patients with T1-T2 hypopharyngeal carcinoma

A real-world study of different reconstruction modalities for patients with T1-T2 hypopharyngeal carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089872
Enrollment
Unknown
Registered
2024-09-18
Start date
2024-09-20
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypopharyngeal carcinoma

Interventions

Skin flap reconstruction group:Surgical treatment of hypopharyngeal carcinoma with skin flap reconstruction.
None skin flap reconstruction group:Surgical treatment of hypopharyngeal carcinoma without skin flap reconstruction.

Sponsors

Eye & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Have signed the research informed consent form and voluntarily joined this clinical study; 2. Age: 20-80 years old; 3. Pathologically diagnosed with hypopharyngeal carcinoma; 4. Patients with surgically resectable T1-T2 hypopharyngeal carcinoma; 5. Preoperatively acceptable to receive neoadjuvant therapy (chemotherapy, targeted therapy, immunotherapy, and/or radiation therapy), but not achieving complete remission (CR).

Exclusion criteria

Exclusion criteria: 1. History of concurrent malignant tumors in other locations (except for papillary thyroid cancer or other early tumors with good treatment results); 2. Preoperative radical treatment for recurrent patients; 3. Poor compliance, unwilling to cooperate with the treatment, or resistant to changes in the treatment plan; 4. Lack of complete clinical information and complete follow-up; 5. Other reasons unsuitable for participation in this clinical study.

Design outcomes

Primary

MeasureTime frame
Surgical site infection after operation;Degree of swallowing function postoperatively;Degree of speech function postoperatively;Postoperative quality of life;Postoperation pain;Postoperation treatment;Disease-free survival;Cancer-specific survival;Overall survival;Flap complication;Treatment of hypopharyngeal carcinoma surgery and skin flap reconstruction;Larynx preservation rate after operation;Preoperative treatment;Progression-free survival;

Secondary

MeasureTime frame
the score of recovery of donor sensory function;Treatment cost;

Countries

China

Contacts

Public ContactChengzhi Xu

Eye & ENT Hospital of Fudan University

xczmed@126.com+86 180 4980 0608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026